Pediatric Use of Recombinant Human Nerve Growth Factor 20 μg/mL Eye Drops (Cenegermin) for Bilateral Neurotrophic Keratopathy in Congenital Corneal Anesthesia
Conclusions:
Cenegermin was effective in treating NK in an infant with Goldenhar syndrome.
Source: Cornea - Category: Opthalmology Tags: Case Report Source Type: research
More News: Anesthesia | Anesthesiology | Brain | Eyes | Italy Health | MRI Scan | Neurology | Opthalmology | Pediatrics | Reflex Sympathetic Dystrophy | Study